Weight Loss News and Research RSS Feed - Weight Loss News and Research

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Data presented today at The International Liver Congress 2015 demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). [More]
Miriam Hospital awarded BDC designation for bariatric surgery

Miriam Hospital awarded BDC designation for bariatric surgery

Blue Cross Blue Shield of Rhode Island has awarded The Miriam Hospital a Blue Distinction Center+ (BDC) designation for bariatric surgery. A designation by the Blue Distinction Centers for Specialty Care program, BDCs are nationally designated health care facilities that deliver quality specialty care based on objective measures for patient safety and better health outcomes. [More]
Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS). [More]
New project to tackle escalating problem of frailty among ageing population in Europe

New project to tackle escalating problem of frailty among ageing population in Europe

A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers. [More]
Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Esophageal cancer is one of the fastest-growing and deadliest cancers in the U.S. According to the American Cancer Society, an estimated 17,000 new cases of esophageal cancer will be diagnosed in 2015. Incidence of adenocarcinoma, a type of esophageal cancer linked to GERD (gastroesophageal reflux disease) has risen six-fold in recent decades. [More]
Researchers examine how probiotics can help improve health, prevent disease

Researchers examine how probiotics can help improve health, prevent disease

In recent years, research into the benefits of gut bacteria has exploded. Scientists across the globe are examining how these microbes can help improve health and prevent disease. [More]
Studies examine positive and negative outcomes of using health apps

Studies examine positive and negative outcomes of using health apps

Health apps have the potential to make a broad impact on the health of the general population, argues one expert in The BMJ this week. But another explains that there is not enough evidence to support such claims and suggests that health apps may even be harmful. [More]
Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ. [More]
Making small changes to protein- and carbohydrate-rich foods is associated with weight loss

Making small changes to protein- and carbohydrate-rich foods is associated with weight loss

Making small, consistent changes to the types of protein- and carbohydrate-rich foods we eat may have a big impact on long-term weight gain, according to a new study led by researchers at the Friedman School of Nutrition Science & Policy at Tufts University. [More]
Newly approved drug for rare blood cancer shows sustained benefit for 2 years

Newly approved drug for rare blood cancer shows sustained benefit for 2 years

The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute. [More]
Commercial weight-loss programs can make significant difference in overall health

Commercial weight-loss programs can make significant difference in overall health

New research published in the Annals of Internal Medicine finds that commercial weight-loss programs can offer significant weight loss after one year of participation when compared to a control group. Researchers led by Kimberly A. Gudzune, M D, MPH, found that participants achieved up to 4.9% mean total weight loss following one year of participation, which could be medically significant for many people with obesity or excess weight. [More]
Exercise benefits obese, overweight people with NAFLD

Exercise benefits obese, overweight people with NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the western world. A new study published in the Journal of Hepatology shows that exercise, regardless of frequency or intensity, benefits obese and overweight adults with NAFLD. [More]
New study analyses physical, psychological consequences of bariatric surgery

New study analyses physical, psychological consequences of bariatric surgery

Bariatric surgery, or reduction of gastric capacity, is one of the longer lasting options to achieve considerable weight loss in obese people. A Spanish researcher has participated in a study that confirms that the effects of this relatively complex medical surgery are not only physical, but also psychological. [More]
Visual Health Solutions launches Visualize You – Weight Change Viewer mobile app

Visual Health Solutions launches Visualize You – Weight Change Viewer mobile app

Visual Health Solutions, Inc., today introduced the Visualize You – Weight Change Viewer mobile app, an ultra-sophisticated weight-loss activation tool that uses a photo to display the effects of weight loss on a user's facial appearance in unprecedented detail. Unlike conventional photo manipulations that only stretch or pinch images, the Visualize You - Weight Change Viewer app generates a stunningly accurate facial image that reflects actual weight change dynamics aligned with an individual's target weight-loss goal. [More]
eRelevance’s progressive patient engagement service sold to 100 Medspa, Plastic Surgery practices

eRelevance’s progressive patient engagement service sold to 100 Medspa, Plastic Surgery practices

eRelevance Corporation, announced today that its progressive patient engagement service has been sold to nearly 100 Medical Spa (Medspa) and Plastic Surgery practices in just the first quarter of 2015. [More]
Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

Clinical trial uses personalized cellular therapy to treat GVHD complication of bone marrow transplant

An innovative clinical trial using the science of "personalized" cellular therapy has begun enrolling children and adults suffering from graft-versus-host-disease (GVHD), a life-threatening complication of bone marrow transplantation in which donor immune lymphocytes attack the organs of the bone marrow transplant recipient. [More]
Bariatric procedure improves outcomes in obese patients looking to get joint replacement

Bariatric procedure improves outcomes in obese patients looking to get joint replacement

According to research presented recently at the annual meeting of the American Academy of Orthopaedic Surgeons, obese patients looking to get a joint replacement are more likely to have success with their hip or knee surgery if they first undergo a bariatric procedure. [More]
EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company has entered into a partnership with American HealthCare Lending to provide funding for patient access to vBloc Therapy, delivered via the Maestro Rechargeable System, for the treatment of obesity. [More]
New research reveals effects of physician advice on weight loss

New research reveals effects of physician advice on weight loss

Patients advised to lose weight by their physicians dropped more pounds on average than those who didn't receive a recommendation, according to new research from the University of Georgia published in the journal Economics & Human Biology. [More]
Antibodies from dromedary camels may prove therapeutic for MERS patients

Antibodies from dromedary camels may prove therapeutic for MERS patients

Antibodies from dromedary camels protected uninfected mice from Middle East Respiratory Syndrome (MERS), and helped infected mice expunge the disease, according to a study published online March 18th in the Journal of Virology, a journal published by the American Society for Microbiology. [More]
Advertisement
Advertisement